CTLA4 and cardiac arrhythmia: This study showed that ICI-associated arrhythmias were over-reported for anti-PD-1/PD-L1 vs anti-CTLA-4 monotherapy [ROR: 1.80 (1.44–2.26) and 2.22 (1.76–2.80), respectively].